210 related articles for article (PubMed ID: 16794639)
21. Testing yourself for HIV.
Cowley G
Newsweek; 1996 May; 127(22):60. PubMed ID: 10158168
[No Abstract] [Full Text] [Related]
22. FDA weighing feasibility of at-home testing for AIDS virus.
AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16331828
[No Abstract] [Full Text] [Related]
23. Patient safety and the next generation of HPV DNA tests.
Lee SH
Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106
[No Abstract] [Full Text] [Related]
24. Modification of In Vitro Diagnostic Devices: Leveling the Playing Field.
Rychert J; Delgado JC; Genzen JR
Clin Chem; 2020 Jun; 66(6):760-762. PubMed ID: 32278318
[No Abstract] [Full Text] [Related]
25. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
[TBL] [Abstract][Full Text] [Related]
26. HIV home tests can be inaccurate.
J Am Osteopath Assoc; 1999 Jul; 99(7):355. PubMed ID: 10441932
[No Abstract] [Full Text] [Related]
27. Progress report: why we still don't have a reliable gold standard for in vitro diagnostic genetic testing.
Murphy MP
MLO Med Lab Obs; 2012 May; 44(5):36, 38. PubMed ID: 22649968
[No Abstract] [Full Text] [Related]
28. Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.
Islam R; Kar S; Ritzén H; Hays A; Tayyem R; Barry C; Keyhani A; Zimmer J; Cruz Caturla M; Couerbe P; Warren M; Khadang A; Bourdage J; Lindley K; Williams D; Hughes N; Sheldon C; Satterwhite C; Vija J; Yu M; Boulay I; Stamatopoulos J; Lin J; Cape S; Estdale S; Thomas E; Dinan A; MacNeill R; Xiao YQ; Garofolo W; Savoie N; Brown M; Rhyne P; Hristopoulos G; Xu A; Goodwin L; Spriggs F; Xu A; Awaiye K; Hayes R; St Charles J; Bouhajib M; DiMarco C; DiMarco L; Savu SR; Bennett P; Kakkanaiah V; Nehls C; Stouffer B; Tabler E; Briscoe C; Karnik S; DuBey I; Kulagina N; Lindsay J; Beaver C; Williard C; Wang H; Feng H; Malone M; Wells E; Fang X; Moussallie M
Bioanalysis; 2019 Apr; 11(7):645-653. PubMed ID: 30993999
[TBL] [Abstract][Full Text] [Related]
29. "Home brew" laboratory tests.
Kisner HJ
Clin Lab Manage Rev; 1999; 13(2):104-6. PubMed ID: 10557868
[No Abstract] [Full Text] [Related]
30. FDA halts 23andMe personal genetic tests. What might this mean for the future of direct-to-consumer testing?
Darnovsky M; Cussins J
MLO Med Lab Obs; 2014 Mar; 46(3):33. PubMed ID: 24696953
[No Abstract] [Full Text] [Related]
31. Do it yourself? Those easy-to-use home medical tests can be anything but. Some are downright misleading.
Smith IK
Time; 2001 Mar; 157(10):95. PubMed ID: 11256013
[No Abstract] [Full Text] [Related]
32. Design Considerations and Assays for Hemocompatibility of FDA-Approved Nanoparticles.
Saha AK; Zhen MS; Erogbogbo F; Ramasubramanian AK
Semin Thromb Hemost; 2020 Jul; 46(5):637-652. PubMed ID: 31404934
[TBL] [Abstract][Full Text] [Related]
33. Coping with the IVD directive.
Gower G
Med Device Technol; 2000 Oct; 11(8):28-9. PubMed ID: 11185185
[TBL] [Abstract][Full Text] [Related]
34. Turf war over diagnostic testing.
Tempero M
J Natl Compr Canc Netw; 2015 Apr; 13(4):375. PubMed ID: 25870372
[No Abstract] [Full Text] [Related]
35. How should we test the tests?
Zuck TF
Transfusion; 1989 Jan; 29(1):3-4. PubMed ID: 2911862
[No Abstract] [Full Text] [Related]
36. The FDA's perspective on clinical laboratory devices. The premarket review and evaluation process.
Aziz KJ; Sliva CA; Gutman SI
Am Clin Lab; 1996; 15(1):10-1. PubMed ID: 10163487
[No Abstract] [Full Text] [Related]
37. Device safety and effectiveness in the pediatric population: a US FDA perspective.
Samuels-Reid J; Cope JU; Morrison AE
Expert Rev Med Devices; 2009 Mar; 6(2):131-5. PubMed ID: 19298160
[TBL] [Abstract][Full Text] [Related]
38. New HIV test. Accurate results in 20 minutes flat.
Nursing; 2003 Jan; 33(1):34. PubMed ID: 12575681
[No Abstract] [Full Text] [Related]
39. Introduction to in vitro diagnostic device regulatory requirements.
Day J
Methods Mol Biol; 2013; 949():103-12. PubMed ID: 23329438
[TBL] [Abstract][Full Text] [Related]
40. Translating Immuno-oncology Biomarkers to Diagnostic Tests: A Regulatory Perspective.
Li Y; Veeraraghavan J; Philip R
Methods Mol Biol; 2020; 2055():701-716. PubMed ID: 31502175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
